Background & Aims: The I1307H allele of the APC gene has been shown to conf
er a modestly elevated risk of colorectal cancel in the Ashkenazi Jewish po
pulation (relative risk, 1.5-1.7). However, it is unclear whether the alter
ation predisposes to adenomas and whether the genetic information can be us
ed in clinical practice. To further address the pathogenic significance of
I1307H, we offered both a genetic test and a screening program to individua
ls considered to be at increased risk for colorectal cancer. We compared th
e prevalence of polyps and their characteristics between carriers and nonca
rriers. Methods: Invitations to participate in a DNA and colonoscopy screen
ing program were mailed, together with a family questionnaire, to 3540 hous
eholds forming the Jewish Community in Ottawa. The I1307K variant was analy
zed in 242 eligible respondents who were selected because they had a person
al or family history of colon cancer. Nearly 80% of these respondents (n =
189; age range, 32-83 years) consented to undergo a single colonoscopic exa
mination. Results: The overall carrier frequency of I1307K in the study gro
up was 10.3%. A higher proportion of heterozygous gene carriers was found i
n the subgroup of colon cancer survivors (27%) than among asymptomatic indi
viduals (8%, P < 0.02). A total of 59 polyps were identified in 44 subjects
. Histologically confirmed adenomatous polyps were diagnosed in 11.8% of ca
rriers and 12.8% of noncarriers (P > 0.5). No significant differences in po
lyp size, multiplicity, location, degree of villosity, or age-dependent pre
valence were found between the 2 groups of participants. Conclusions: The h
igh frequency of I1307K colorectal cancer patients found in the Ashkenazi J
ewish community of Ottawa and the equivalent proportion of carriers and non
carriers who developed adenomatous polyps suggest that in this community, I
1307K is associated with a significant predisposition to carcinoma but not
adenoma.